Corticosteroid pharmacogenetics: Association of sequence variants in CRHR1 with inproved lung function in asthmatics treated with inhaled corticosteroids

Human Molecular Genetics

Volumn 13, Issue 13, 2004, Pages 1353-1359

  Tantisira, Kelan G ^a,b   Lake, Stephen ^a   Silverman, Eric E ^b   Palmer, Lyle J ^c   Lazarus, Ross ^a   Silverman, Edwin K ^a,b   Liggett, Stephen B ^d   Gelfand, Erwin W ^e   Rosenwasser, Lanny J ^e   Richter, Brent ^a   Israel, Elliot ^b   Wechsler, Michael ^a,b   Gabriel, Stacey ^f,h   Altshuler, David ^f,g,h   Lander, Eric ^f,h   Drazen, Jefferey ^b   Weiss, Scott T ^a  

^a CHANNING LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF CINCINNATI   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f Eli and Edythe L Board Institute   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; FLUNISOLIDE; HYDROCORTISONE; PLACEBO; SALMETEROL; TRIAMCINOLONE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PHARMACOGENETICS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; VARIATION (GENETICS);

EID: 3242687981     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh149     Document Type: Article

References (28)

1. Thomsen, O.O., Cortot, A., Jewell, D., Wright, J.P., Winter, T., Veloso, F.T., Vatn, M., Persson, T. and Pettersson, E. (1998) A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N. Engl. J. Med., 339, 370-374.
2. Hiraoka, M., Tsukahara, H., Matsubara, K., Tsurusawa, M., Takeda, N., Haruki, S., Hayashi, S., Ohta, K., Momoi, T., Ohshima, Y. et al. (2003) A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am. J Kidney Dis., 41, 1155-1162.
3. Von Mutius, E. (2000) Presentation of new GINA guidelines for paediatrics. The global initiative on asthma. Clin. Exp. Allergy, 30 (Suppl. 1), 6-10.
4. Rossi, N., Dalfino, T., Verrotti, A., Di Gioacchino, M., Chiarelli, F. and Warner, J.O. (2001) Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Allergy Asthma Proc., 22, 297-302 (see comments).
5. NHLBI (1997) Highlights of the Expert Panel Report 2: Guidelines for the Diagnosis and Treatment of Asthma 97-4051A. NIH Publications, Bethesda, MD, 50 pp.
6. Malmstrom, K., Rodriguez-Gomez, G., Guerra, J., Villaran, C., Pineiro, A., Wei, L.X, Seidenberg, B.C. and Reiss, T.F. (1999) Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann. Intern. Med., 130, 487-495.
7. Szefler, S.J., Martin, R.J., King, T.S., Boushey, H.A., Chemiack, R.M., Chinchilli, V.M., Craig, T.J., Dolovich, M., Drazen, J.M., Fagan, J.K. et al. (2002) Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol., 109, 410-418.
8. Drazen, J.M., Silverman, E.K. and Lee, T.H. (2000) Heterogeneity of therapeutic responses in asthma. Br. Med. Bull., 56, 1054-1070.
9. Johnson, G.C., Esposito, L., Barratt, B.J., Smith, A.N., Heward, J., Di Genova, G., Ueda, H., Cordell, H.J., Eaves, I.A., Dudbridge, F. et al. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet., 29, 233-237.
10. Sakai, K., Yamada, M., Horiba, N., Wakui, M., Demura, H. and Suda, T. (1998) The genomic organization ofthe human corticotropin-releasing factor type-1 receptor. Gene, 219, 125-130.
11. Pisarchik, A. and Slominski, A.T. (2001) Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J., 15, 2754-2756.
12. Liaw, CW., Grigoriadis, D.E., Lovenberg, T.W., De Souza, E.B. and Maki, R.A. (1997) Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach. Mol. Endocrinol., 11, 980-985.
13. Dautzenberg, F.M., Kilpatrick, G.J., Hanger, R.L. and Moreau, J. (2001) Molecular biology of the CRH receptors - in the mood. Peptides, 22, 753-760.
14. Xu, G., Rabadan-Diehl, C., Nikodemova, M., Wynn, P., Spiess, J. and Aguilera, G. (2001) Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5′ untranslated region. Mol. Pharmacol., 59, 485-492.
15. Elenkov, I.J., Webster, E.L., Torpy, D.J. and Chrousos, G.P. (1999) Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann. NY Acad. Sci., 876, 1-11 (discussion 11-13).
16. Dautzenberg, F.M. and Hauger, R.L. (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci., 23, 71-77.
17. Drolet, G. and Rivest, S. (2001) Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides, 22, 761-767.
18. Habib, K.E., Weld, K.P., Rice, K.C., Pushkas, J., Champoux, M., Listwak, S., Webster, E.L., Atkinson, A.J., Schulkin, J., Contoreggi, C. et al. (2000) Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl Acad. Sci. USA, 97, 6079-6084.
19. Funada, M., Hara, C. and Wada, K. (2001) Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. Eur. J. Pharmacol., 430, 277-281.
20. Theoharides, T.C., Singh, L.K., Boucher, W., Pang, X., Letoumeau, R., Webster, E. and Chrousos, G. (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology, 139, 403-413.
21. Childhood Asthma Management Program Research Group (1999) The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control. Clin. Trials, 20, 91-120.
22. The Childhood Asthma Management Program Research Group (2000) Long-term effects of budesonide or nedocromil in children with asthma. N. Engl. J. Med., 343, 1054-1063.
23. Lazarus, S.C., Boushey, H.A., Fahy, J.V., Chinchilli, V.M., Lemanske, R.F., Jr, Sorkness, C.A., Kraft, M., Fish, J.E., Peters, S.P., Craig, T. et al. (2001) Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. J. Am. Med. Assoc., 285, 2583-2593.
24. Lemanske, R.F., Jr, Sorkness, C.A., Mauger, E.A., Lazarus, S.C., Boushey, H.A., Fahy, J.V., Drazen, J.M., Chinchilli, V.M., Craig, T., Fish, J.E. et al. (2001) Inhaled corticosteroid reducton and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. J. Am. Med. Assoc., 285, 2594-2603.
25. Sun, X., Ding, H., Hung, K. and Goo, B. (2000) A new MALDI-TOF based mini-sequencing assay for genotyping of SNPs. Nucl. Acids Res., 28, E68.
26. Stephens, M., Smith, N.J. and Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
27. Sebastiani, P., Lazarus, R., Weiss, S.T., Kunkel, L.M., Kohane, I.S. and Ramoni, M.F. (2003) Minimal haplotype tagging. Proc. Natl Acad. Sci. USA, 100, 9900-9905.
28. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.